Logo

American Heart Association

  19
  0


Final ID: MP278

Early Partial ECMO Flow Is Associated With Higher Survival in Patients With Cardiogenic Shock With Reduced and Preserved Systemic Pulse Pressure: An ELSO Registry Analysis

Abstract Body (Do not enter title and authors here): Introduction: In cardiogenic shock (CS) patients supported with venoarterial extracorporeal membrane oxygenation (VA-ECMO), emerging observational evidence suggests potential benefit from the use of a partial ECMO flow strategy, but whether these findings extend across a spectrum of residual native heart function is unknown. Systemic pulse pressure (PP) is a reasonable surrogate of native heart function during ECMO support, and the interaction between early ECMO flow and PP is not well understood. Hypothesis: CS patients receiving VA-ECMO with early partial versus full ECMO flow will have higher inpatient survival across both reduced and preserved PP at 24 hours of support. Methods: We queried the ELSO Registry (2018–2023) for adults with CS supported with VA-ECMO, excluding patients with ECPR or with a concomitant left ventricular mechanical unloading device. At 24 hours of support, patients were stratified into four groups based on ECMO flow index (partial <2.0 vs full ≥2.0 L/min/m2 flow) and PP (reduced < 30mmHg versus preserved ≥30 mmHg). The primary outcome of 60-day in-hospital survival was compared using Kaplan-Meier time-to-event analysis and multivariable Cox proportional hazards modeling. Results: Among 5,274 CS patients receiving VA-ECMO, 50% had preserved pulse pressure and 56% received partial flow at 24 hours. Patients with preserved PP receiving partial flow had markers of lower baseline illness severity compared to the other groups (Table 1). Patients with preserved PP and partial flow had the highest 60-day survival at 61%, while those with reduced PP and full flow had the lowest survival at 45% (log-rank p<0.001) (Figure 1). This relationship between flow index and PP groups with survival persisted in multivariable Cox modeling (Table 2). Partial flow was associated with significantly higher inpatient survival in both PP groups: 61% vs 57% in patients with PP ≥30 mmHg (log-rank p=0.021) and 50% vs 45% in patients with PP <30 mmHg (log-rank p=0.033). Conclusions: Among adults with CS supported on VA-ECMO, the use of partial versus full ECMO flow at 24 hours was associated with higher 60-day in-hospital survival in patients with both reduced and preserved systemic pulse pressure, suggesting potential benefit of a partial flow strategy across a spectrum of residual native heart function.
  • Delgado, Alvaro  ( Beth Israel Deaconess Medical Center , Boston , Massachusetts , United States )
  • Rali, Aniket  ( Vanderbilt University Medical Center , Nashville , Tennessee , United States )
  • Garan, Arthur Reshad  ( Beth Israel Deaconess Medical Center , Boston , Massachusetts , United States )
  • Grandin, E. Wilson  ( Beth Israel Deaconess Medical Center , Boston , Massachusetts , United States )
  • Aguilar, Laura  ( Beth Israel Deaconess Medical Center , Boston , Massachusetts , United States )
  • Maffioletti Goncalves, Lucas  ( Beth Israel Deaconess Medical Center , Boston , Massachusetts , United States )
  • Ho, Jennifer  ( Beth Israel Deaconess Medical Center , Boston , Massachusetts , United States )
  • Oseran, Andrew  ( Beth Israel Deaconess Medical Center , Boston , Massachusetts , United States )
  • Hyland, Patrick  ( Beth Israel Deaconess Medical Center , Boston , Massachusetts , United States )
  • Quintero Pinzon, Pablo  ( Beth Israel Deaconess Medical Center , Boston , Massachusetts , United States )
  • Upshaw, Jenica  ( Beth Israel Deaconess Medical Center , Boston , Massachusetts , United States )
  • Sabe, Marwa  ( Beth Israel Deaconess Medical Center , Boston , Massachusetts , United States )
  • Author Disclosures:
    Alvaro Delgado: DO NOT have relevant financial relationships | Aniket Rali: DO have relevant financial relationships ; Consultant:Abiomed:Active (exists now) ; Consultant:Vectorious:Active (exists now) ; Consultant:Analog Devices:Past (completed) ; Consultant:CareTaker Medical:Active (exists now) ; Speaker:Zoll:Active (exists now) | Arthur Reshad Garan: DO have relevant financial relationships ; Consultant:NuPulseCV:Active (exists now) ; Other (please indicate in the box next to the company name):Maquet/Getinge:Past (completed) ; Advisor:Boston Scientific:Active (exists now) ; Advisor:Abiomed:Active (exists now) | E. Wilson Grandin: No Answer | Laura Aguilar: DO NOT have relevant financial relationships | Lucas Maffioletti Goncalves: DO NOT have relevant financial relationships | Jennifer Ho: DO have relevant financial relationships ; Individual Stocks/Stock Options:Pfizer:Active (exists now) ; Consultant:Lilly:Active (exists now) | Andrew Oseran: DO have relevant financial relationships ; Consultant:Agilon Health:Active (exists now) | Patrick Hyland: DO NOT have relevant financial relationships | Pablo Quintero Pinzon: DO NOT have relevant financial relationships | Jenica Upshaw: DO NOT have relevant financial relationships | Marwa Sabe: DO have relevant financial relationships ; Advisor:NovoNordisk:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Powering the Failing Heart: Advances and Outcomes in Mechanical Support and Transplantation

Saturday, 11/08/2025 , 01:45PM - 03:00PM

Moderated Digital Poster Session

More abstracts on this topic:
β1 Adrenergic Receptor Autoantibodies Promote Heart Failure Though Activation of Prostaglandin E2 Receptor EP1/Phosphodiesterase 4B Pathway

Cao Ning, Qiu Hui, Li Hongwei

Adverse Events and Outcomes Among Patients with Temporary Mechanical Circulatory Support Devices Placed at Referring Versus Hub Cardiogenic Shock Centers

Patel Zachary, Silkowski Molly, Dodson Kaylen, Bull Lindsey, Gregoski Mathew, Tedford Ryan, Mcmurray Jeffrey, Witer Lucas, Kilic Arman, Houston Brian, Carnicelli Anthony, Ospina Meg, Mittelstaedt Roxanne, Peller Jacob, Samani Stephanie, Marchell Charlotte, Ohlrich Kelly, Gunn Brady, Varrone Michael

More abstracts from these authors:
Comparison of Patient Demographics between New and Existing Heart Transplant Centers

Zhang Amy, Fleming Lisa, Guardino Cara, Wadhera Rishi, Tsukioka Yusuke, Aguilar Laura, Delgado Alvaro, Maffioletti Goncalves Lucas, Kai Masashi, Garan Arthur Reshad, Zhang Cancan, Quintero Pablo, Grandin E. Wilson, Oseran Andrew, Ho Jennifer, Hyland Patrick, Upshaw Jenica, Sabe Marwa

Impact of New Heart Transplant Centers on Regional Transplant Volume and Outcomes

Zhang Amy, Fleming Lisa, Guardino Cara, Wadhera Rishi, Tsukioka Yusuke, Aguilar Laura, Delgado Alvaro, Maffioletti Goncalves Lucas, Kai Masashi, Garan Arthur Reshad, Zhang Cancan, Quintero Pablo, Grandin Edward, Oseran Andrew, Ho Jennifer, Hyland Patrick, Upshaw Jenica, Sabe Marwa

You have to be authorized to contact abstract author. Please, Login
Not Available